LPL Financial’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.8M Sell
2,128,391
-77,846
-4% -$3.48M 0.02% 718
2026
Q1
$106M Buy
2,206,237
+394,119
+22% +$18.4M 0.03% 549
2025
Q4
$87.8M Buy
1,812,118
+68,801
+4% +$3.41M 0.02% 606
2025
Q3
$82.3M Buy
1,743,317
+59,562
+4% +$2.87M 0.02% 613
2025
Q2
$81.3M Buy
1,683,755
+163,034
+11% +$8.33M 0.03% 561
2025
Q1
$84.3M Buy
1,520,721
+236,625
+18% +$12.8M 0.03% 479
2024
Q4
$61.9M Buy
1,284,096
+142,290
+12% +$7.23M 0.03% 559
2024
Q3
$65.8M Buy
1,141,806
+59,247
+5% +$3.2M 0.03% 512
2024
Q2
$52.5M Buy
1,082,559
+208,984
+24% +$10.1M 0.03% 539
2024
Q1
$42.5M Buy
873,575
+208,410
+31% +$10.2M 0.02% 596
2023
Q4
$33.1M Sell
665,165
-79,392
-11% -$3.88M 0.02% 656
2023
Q3
$39.9M Buy
744,557
+50,729
+7% +$2.7M 0.03% 529
2023
Q2
$37.4M Buy
693,828
+154,602
+29% +$8.32M 0.03% 535
2023
Q1
$29.3M Buy
539,226
+348,533
+183% +$17M 0.02% 599
2022
Q4
$9.24M Buy
190,693
+15,799
+9% +$693K 0.01% 1069
2022
Q3
$6.65M Buy
174,894
+34,551
+25% +$1.54M 0.01% 1185
2022
Q2
$7.02M Sell
140,343
-778
-0.6% -$41.3K 0.01% 1166
2022
Q1
$7.25M Buy
141,121
+20,188
+17% +$1.04M 0.01% 1198
2021
Q4
$6.06M Buy
120,933
+21,547
+22% +$1.07M 0.01% 1331
2021
Q3
$4.79M Sell
99,386
-884
-0.9% -$45K ﹤0.01% 1422
2021
Q2
$5.28M Buy
100,270
+10,549
+12% +$550K 0.01% 1307
2021
Q1
$4.44M Buy
89,721
+14,666
+20% +$705K 0.01% 1311
2020
Q4
$3.65M Buy
75,055
+2,278
+3% +$112K ﹤0.01% 1290
2020
Q3
$3.65M Buy
72,777
+6,237
+9% +$321K 0.01% 1114
2020
Q2
$3.4M Buy
66,540
+5,484
+9% +$267K 0.01% 1057
2020
Q1
$2.67M Buy
61,056
+8,611
+16% +$412K 0.01% 1028
2019
Q4
$2.63M Buy
52,445
+2,552
+5% +$120K ﹤0.01% 1183
2019
Q3
$2.31M Buy
49,893
+1,175
+2% +$50.7K ﹤0.01% 1171
2019
Q2
$2.11M Buy
48,718
+1,153
+2% +$49K ﹤0.01% 1220
2019
Q1
$2.11M Buy
47,565
+1,164
+3% +$49.9K ﹤0.01% 1173
2018
Q4
$2.01M Sell
46,401
-3,397
-7% -$150K 0.01% 1069
2018
Q3
$2.22M Sell
49,798
-157,330
-76% -$6.72M 0.01% 1112
2018
Q2
$8.29M Sell
207,128
-40,983
-17% -$1.61M 0.02% 520
2018
Q1
$9.94M Buy
248,111
+114,452
+86% +$4.76M 0.03% 453
2017
Q4
$5.75M Sell
133,659
-49,393
-27% -$2.28M 0.02% 604
2017
Q3
$9.11M Buy
183,052
+14,207
+8% +$687K 0.03% 402
2017
Q2
$8.09M Buy
168,845
+128,284
+316% +$6.13M 0.03% 419
2017
Q1
$1.83M Buy
40,561
+1,747
+5% +$74.1K 0.01% 895
2016
Q4
$1.57M Sell
38,814
-377
-1% -$14.9K 0.01% 920
2016
Q3
$1.5M Buy
39,191
+9,408
+32% +$378K 0.01% 922
2016
Q2
$1.24M Sell
29,783
-153,582
-84% -$6.3M 0.01% 1025
2016
Q1
$7.55M Buy
183,365
+24,423
+15% +$981K 0.02% 539
2015
Q4
$6.72M Buy
158,942
+77,728
+96% +$3.58M 0.02% 588
2015
Q3
$3.98M Sell
81,214
-8,387
-9% -$427K 0.02% 543
2015
Q2
$4.32M Buy
89,601
+37,825
+73% +$1.92M 0.02% 576
2015
Q1
$2.58M Buy
51,776
+14,004
+37% +$670K 0.01% 791
2014
Q4
$1.72M Buy
37,772
+5,713
+18% +$277K 0.01% 979
2014
Q3
$1.79M Buy
32,059
+3,361
+12% +$181K 0.01% 912
2014
Q2
$1.53M Buy
28,698
+3,148
+12% +$167K 0.01% 1054
2014
Q1
$1.34M Sell
25,550
-42,620
-63% -$2.16M 0.01% 1078
2013
Q4
$3.66M Sell
68,170
-5,343
-7% -$276K 0.02% 548
2013
Q3
$3.68M Sell
73,513
-1,483
-2% -$75.5K 0.02% 519
2013
Q2
$3.86M Buy
+74,996
New +$4M 0.03% 460

Other funds holding SNY

LPL Financial's SNY Position: Q2 2026 in Review

LPL Financial reduced its Sanofi (SNY) stake by 3.5% in Q2 2026, selling an estimated $3.48M and leaving 2,128,391 shares worth $90.8M. The position accounts for 0.02% of the portfolio, ranked #718.

LPL Financial first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $106M in Q1 2026. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • LPL Financial held 2,128,391 shares of Sanofi worth $90.8M as of Q2 2026.
  • LPL Financial sold 77,846 Sanofi shares in Q2 2026, an estimated $3.48M.
  • Sanofi made up 0.02% of LPL Financial's portfolio in Q2 2026, its #718 holding.
  • LPL Financial first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
  • LPL Financial's Sanofi position peaked at $106M in Q1 2026.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.